SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-457464
Filing Date
2012-11-07
Accepted
2012-11-07 16:16:05
Documents
12
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398719d10q.htm 10-Q 760412
2 EX-10.1 d398719dex101.htm EX-10.1 9727
3 EX-31.1 d398719dex311.htm EX-31.1 6559
4 EX-31.2 d398719dex312.htm EX-31.2 6555
5 EX-32.1 d398719dex321.htm EX-32.1 3466
6 EX-32.2 d398719dex322.htm EX-32.2 3462
  Complete submission text file 0001193125-12-457464.txt   5017955

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tsrx-20120930.xml EX-101.INS 705418
8 XBRL TAXONOMY EXTENSION SCHEMA tsrx-20120930.xsd EX-101.SCH 48366
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tsrx-20120930_cal.xml EX-101.CAL 48807
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tsrx-20120930_def.xml EX-101.DEF 133084
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsrx-20120930_lab.xml EX-101.LAB 348369
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsrx-20120930_pre.xml EX-101.PRE 256730
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34828 | Film No.: 121186952
SIC: 2834 Pharmaceutical Preparations